Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017–2024): a retrospective, multicentre cohort study

Sofía L.J. Peeters, Niels Heersche, Doortje Böhm, Stefan Böhringer, Roselien Guiljam, Emma C. Hulshof, Femke M. de Man, Mirjam de With, Marije Joosse, Gysella Oomens, Qiong-Yi Wu, Aisha Osman, Sander Bins, Irene E.G. van Hellemond, Brigitte C.M. Haberkorn, Arjan J. Verschoor, Miriam L. Wumkes, Ron H.N. van Schaik, Anna M. Thijs, Hans Gelderblom, Henk-Jan Guchelaar, Ron H.J. Mathijssen, Maarten J. Deenen

Open source

DOI: 10.1016/j.lanepe.2026.101629
Published: 2026-05
Container: The Lancet Regional Health - Europe
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanepe.2026.101629,
  title = {Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017–2024): a retrospective, multicentre cohort study},
  author = {Sofía L.J. Peeters and Niels Heersche and Doortje Böhm and Stefan Böhringer and Roselien Guiljam and Emma C. Hulshof and Femke M. de Man and Mirjam de With and Marije Joosse and Gysella Oomens and Qiong-Yi Wu and Aisha Osman and Sander Bins and Irene E.G. van Hellemond and Brigitte C.M. Haberkorn and Arjan J. Verschoor and Miriam L. Wumkes and Ron H.N. van Schaik and Anna M. Thijs and Hans Gelderblom and Henk-Jan Guchelaar and Ron H.J. Mathijssen and Maarten J. Deenen},
  year = {2026},
  journal = {The Lancet Regional Health - Europe},
  doi = {10.1016/j.lanepe.2026.101629},
  url = {https://doi.org/10.1016/j.lanepe.2026.101629}
}

RIS

TY  - JOUR
TI  - Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017–2024): a retrospective, multicentre cohort study
AU  - Sofía L.J. Peeters
AU  - Niels Heersche
AU  - Doortje Böhm
AU  - Stefan Böhringer
AU  - Roselien Guiljam
AU  - Emma C. Hulshof
AU  - Femke M. de Man
AU  - Mirjam de With
AU  - Marije Joosse
AU  - Gysella Oomens
AU  - Qiong-Yi Wu
AU  - Aisha Osman
AU  - Sander Bins
AU  - Irene E.G. van Hellemond
AU  - Brigitte C.M. Haberkorn
AU  - Arjan J. Verschoor
AU  - Miriam L. Wumkes
AU  - Ron H.N. van Schaik
AU  - Anna M. Thijs
AU  - Hans Gelderblom
AU  - Henk-Jan Guchelaar
AU  - Ron H.J. Mathijssen
AU  - Maarten J. Deenen
PY  - 2026
JO  - The Lancet Regional Health - Europe
DO  - 10.1016/j.lanepe.2026.101629
UR  - https://doi.org/10.1016/j.lanepe.2026.101629
ER  -

APA

Peeters, S. L., Heersche, N., Böhm, D., Böhringer, S., Guiljam, R., Hulshof, E. C., Man, F. M. D., With, M. D., Joosse, M., Oomens, G., Wu, Q., Osman, A., Bins, S., Hellemond, I. E. V., Haberkorn, B. C., Verschoor, A. J., Wumkes, M. L., Schaik, R. H. V., Thijs, A. M., Gelderblom, H., Guchelaar, H., Mathijssen, R. H., & Deenen, M. J. (2026). Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017–2024): a retrospective, multicentre cohort study. The Lancet Regional Health - Europe. https://doi.org/10.1016/j.lanepe.2026.101629

Source records

crossref · retrieved 2026-09-26T09:44:55.382Z